New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a new liquid biopsy test that can be used to predict risk of early disease progression in women with metastatic breast cancer. This could help oncologists by optimizing the use of available and effective therapies with the goal of achieving better clinical outcomes and prolonging survival. Read more about the study here.

SEE ALL NEWS

Recent Posts

Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment Cancer treatments based on our internal clock could improve outcomes First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma